Oculis Holding AG (OCS)
23.07
+1.04
(+4.72%)
USD |
NASDAQ |
Jan 09, 16:00
23.01
-0.06
(-0.26%)
Pre-Market: 20:00
Oculis Price to Book Value: 8.125 for Jan. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| BeOne Medicines Ltd. | 9.842 |
| AC Immune SA | 4.371 |
| CRISPR Therapeutics AG | 2.678 |
| Addex Therapeutics Ltd. | 1.285 |
| NewCelX Ltd. | -- |
Price to Book Value Related Metrics
| PEG Ratio | -0.3643 |
| Price | 23.07 |
| Earnings Yield | -10.92% |
| Market Cap | 1.334B |
| PEGY Ratio | -0.3643 |